Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MicroMed Technology
AddedFeb 15, 2024
UpdatedJun 18, 2026
MicroMed Technology

MicroMed Technology

Series D

Health tech firm offering a compact, cost-effective heart assist device, developed with NASA, for transplant wait-list patients.

HQ
Houston, TX, US
Founded
1998
Overview
Compare
Fundraising
Employees
Website

MicroMed Technology, founded to address the critical need for heart transplant solutions, focuses on developing advanced health technology. Its core mission is to provide life-saving devices for patients awaiting heart transplants. The company’s flagship product, the MicroMed DeBakey VAD®, is a compact, cost-effective heart assist device created in collaboration with Dr. Michael DeBakey, Dr. George Noon, and NASA. This device is designed to sustain patients until a donor heart becomes available, significantly improving their survival chances.

Notable figures affiliated with MicroMed Technology include renowned cardiovascular surgeons Dr. Michael DeBakey and Dr. George Noon. The company has achieved significant milestones, including the development of a ventricular assist device that is a fraction of the size of traditional pulsatile products. This innovation has had a profound impact on the healthcare industry by providing a silent, lightweight solution for heart failure patients, enhancing their quality of life while they await transplants.

MicroMed Technology - Similar Companies

Micro Medical Solutions logo

Micro Medical Solutions

Micro Interventional Devices logo

Micro Interventional Devices

TransMedics logo

TransMedics

transmedics.com

MicroPort Scientific logo

MicroPort Scientific

Medical Device Innovations logo

Medical Device Innovations

Microbot Medical logo

Microbot Medical

KitoTech Medical logo

KitoTech Medical

MicroPort CardioFlow logo

MicroPort CardioFlow

Cardiomems logo

Cardiomems

Neocardial Technologies logo

Neocardial Technologies

neocardial.com

Vadovations logo

Vadovations

Moray Medical logo

Moray Medical

moraymedical.com

Medical 21 logo

Medical 21

medical21.com

Micron Solutions logo

Micron Solutions

MyoCardioCare logo

MyoCardioCare

myocardiocare.com

MicroMed Technology - Quick Facts

Who are MicroMed Technology's competitors?

Companies similar to MicroMed Technology include Micro Medical Solutions, Micro Interventional Devices, TransMedics and MicroPort Scientific.

When was MicroMed Technology founded?

MicroMed Technology was founded in 1998.

Where is MicroMed Technology's headquarters located?

MicroMed Technology's headquarters is located in Houston, TX, US.

When was MicroMed Technology's last funding round?

MicroMed Technology's most recent funding round was for $23M (USD) in October 2002.

How much has MicroMed Technology raised to-date?

As of Oct 2, 2002, MicroMed Technology has raised a total of $40.6M (USD).

How many employees does MicroMed Technology have?

MicroMed Technology has 13 employees as of Feb 5, 2024.

MicroMed Technology - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • HealthTech
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified